On paper great. - Bioinformatics Scientist bei NeoGenomics: Mitarbeiterbewertung

3.0
5. Sept. 2024
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Lots of benefits like pension, health insurance, life insurance, enhanced maternity leave, and decent pay.

Kontras

R&D department focus is messy, and always changing, reducing the sense of stability and making it difficult to plan a career growth.

Mehr Bewertungen zu NeoGenomics entdecken

5.0
11. März 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Growing business opportunities for many job seekers

Kontras

Ever changing approach on direction on projects

2.0
2. März 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Kontras

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle